Table 2.
Variable | Univariate | P value | Multivariate | P value | ||
---|---|---|---|---|---|---|
HR | 95%CI | HR | 95%CI | |||
Age | ||||||
17-30 | Reference | Reference | ||||
30-40 | 0.67 | 0.40-1.10 | 0.11 | 0.78 | 0.47-1.30 | 0.35 |
40-50 | 0.55 | 0.34-0.88 | <0.01 | 0.71 | 0.44-1.14 | 0.16 |
Race | ||||||
Black | Reference | Reference | ||||
White | 0.63 | 0.45-0.90 | <0.01 | 0.67 | 0.74-1.42 | 0.13 |
Other | 0.95 | 0.63-1.43 | 0.82 | 1 | 0.66-1.51 | 0.87 |
Sex | ||||||
F | Reference | Reference | ||||
M | 1.53 | 1.23-1.90 | <0.01 | 1.45 | 1.16-1.82 | <0.01 |
Pathology | ||||||
Adenocarcinoma | Reference | Reference | ||||
Mucinous and signet ring cell carcinoma | 2.09 | 1.47-2.99 | <0.01 | 1.49 | 1.03-2.15 | <0.01 |
Others | 2.05 | 1.36-3.09 | <0.01 | 1.47 | 0.96-2.25 | 0.07 |
Grade | ||||||
I | Reference | Reference | ||||
II | 1.81 | 0.99-3.32 | 0.07 | 1.69 | 0.92-3.12 | 0.08 |
III | 4.12 | 2.19-7.72 | <0.01 | 2.66 | 1.40-5.05 | <0.01 |
IV | 3.51 | 1.52-8.01 | <0.01 | 2.62 | 1.12-6.12 | <0.01 |
Stages T a | ||||||
T1 | Reference | Reference | ||||
T2 | 4.51 | 2.14-6.38 | <0.01 | 5.37 | 0.69-3.12 | 0.10 |
T3 | 2.65 | 1.94-3.71 | <0.01 | 3.14 | 1.57-4.65 | <0.01 |
T4 | 5.76 | 3.61-6.82 | <0.01 | 6.77 | 4.83-8.15 | <0.01 |
Stages N a | ||||||
N0 | Reference | Reference | ||||
N1 | 1.53 | 1.15-2.09 | <0.01 | 1 | 0.68-1.47 | 0.98 |
N2 | 2.97 | 2.21-3.99 | <0.01 | 1.01 | 0.65-1.59 | 0.93 |
Tumor size | ||||||
0-5 | Reference | Reference | ||||
5-10 | 1.27 | 1.02-1.57 | <0.01 | 1.08 | 0.87-1.36 | 0.45 |
>10 | 2.2 | 1.43-3.38 | <0.01 | 0.98 | 0.60-1.58 | 0.94 |
Number | ||||||
1 | Reference | Reference | ||||
>1 | 1.33 | 0.91-1.95 | 0.13 | 1.44 | 0.95-2.13 | 0.06 |
LNR | ||||||
0 | Reference | Reference | ||||
0-0.20 | 1.53 | 1.17-1.99 | <0.01 | 1.75 | 1.22-2.50 | <0.01 |
0.2-0.4 | 3.19 | 2.38-4.28 | <0.01 | 3.28 | 2.18-4.91 | <0.01 |
>0.4 | 4.31 | 3.18-5.84 | <0.01 | 3.57 | 2.32-5.48 | <0.01 |
CEA | ||||||
Positive | Reference | Reference | ||||
Negative | 0.52 | 0.42-0.64 | <0.01 | 0.65 | 0.52-0.81 | <0.01 |
Radiation | ||||||
No | Reference | Reference | ||||
Yes | 0.59 | 0.45-0.78 | <0.01 | 0.56 | 0.41-0.77 | <0.01 |
Chemotherapy | ||||||
Yes | Reference | Reference | ||||
No | 0.67 | 0.44-1.02 | 0.06 | 1.32 | 0.83-2.10 | 0.23 |
AJCC (TNM) Stages: The eighth edition AJCC (TNM) staging system.